Overview | Agenda | Faculty Materials | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home






National Pharma Audioconference: Ten Emerging Risk Areas for Drug and Device Companies

Wednesday, June 16, 2010

1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)


AUDIOCONFERENCE FACULTY

Daniel R. Miller, Esq.
Partner, Berger & Montague, Immediate Past President, National Association of Medicaid Fraud Control Units ("NAMFCU"), Former Deputy Attorney General and Director, Medicaid Fraud Unit, Delaware Department of Justice, Philadelphia, PA

William A. Sarraille, Esq.
Partner, Sidley Austin, Washington, DC



Matthew Hay
Editor, Rx Compliance Report, Washington, DC (Moderator)


TEN EMERGING RISK AREAS TO BE ADDRESSED
  • The rise in medical device qui tam suits
  • New trends in off-label marketing suits: A review of the Seroquel and Topomax cases
  • Prosecutors target the science behind off-label uses
  • The growing risks associated with the rise of individual certifications
  • The threat of third-party payor suits in the wake of Pfizer's $142 million jury verdict
  • How the RICO statute is becoming the latest weapon in the prosecutorial arsenal
  • Understanding the increasing importance of interactions with payers, pharmacies and others
  • Assess the potential impact of disclosures under the Sunshine Act
  • How changes in the False Claims Act may increase corporate exposure

SAVE THE DATE
ELEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
Media Partner: Harvard Health Policy Review
October 20 - 22, 2010
Washington, DC
www.PharmaCongress.com


SPONSORED BY:











We subscribe to the HONcode principles of the HON Foundation. Click to verify.



Overview | Agenda | Faculty Materials | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home




© Health Care Conference Administrators
Contact Webmaster